The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.

BOSTON & MENLO PARK, Calif. & NEW YORK & LONDON, February 03, 2025--(BUSINESS WIRE)--Summit Partners, a leading growth-focused investment firm, today announced the promotion of eight professionals ...

“We are very pleased to recognize the achievements of our colleagues with these well-deserved promotions,” said Peter Chung, managing director and CEO of Summit Partners, in a statement.

The Pfizer company logo is displayed as traders work on the floor of the New York Stock Exchange during morning trading on April 10, 2023 in New York City.

(Bloomberg) -- Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.